DZ BANK upgraded Sartorius (ETR:SRT) to Buy in a report released today.
- Updated: September 16, 2016
DZ BANK has upgraded Sartorius(ETR:SRT) to Buy in a statement released on 9/16/2016.
On 8/31/2016, Commerzbank AG reported on Sartorius(ETR:SRT) upped the target price from 0.00EUR to 56.00EUR that indicated a possible downside of -0.22%.
Only yesterday Sartorius (ETR:SRT) traded 2.17% higher at 74.44EUR. SRT’s 50-day average is 4.94EUR and its 200-day average is 4.48EUR. The last stock price close is up 26.24% from the 200-day average, compared to the Standard & Poor’s 500 Index which has decreased -0.01% over the date range. Trade volume was was down over the average, with 10,732 shares of SRT changing hands under the typical 11,765 shares..
Sartorius has a 52 week low of 3.25EUR and a 52 week high of 5.83EUR and has a total market value of 0.0 EUR.
In addition to DZ BANK reporting it’s price target, a total of 2 equity analysts have reported on Sartorius. The 12-month target is 5.50EUR with 0 rating the stock a strong buy, 0 rating the company a buy, two analyts rating the stock a hold, 0 rating the company to underperform, and finally 0 firmsrating the company as sell.
Brief Synopsis On Sartorius (ETR:SRT)
Sartorius AG is a Germany-based holding company engaged in the provision of laboratory and process technologies, as well as equipment. The Company operates three business segments: Bioprocess Solutions; Lab Products & Services, and Industrial Weighing. The Bioprocess Solutions segment provides integrated solutions for the pharmaceutical industry, including filtration systems, process control tools, purification equipment and fluid management, among others. The Lab Products & Services segment is a supplier of laboratory instruments, consumables and services for the pharmaceutical research and quality assurance laboratories, chemical and food industries as well as for the academic sector. The Industrial Weighing segment provides a range of measurement and inspection systems primarily for the food processing, chemical, pharmaceutical and basic materials sectors. The Company’s activities are carried out via subsidiaries primarily in Europe, and North America and Asia/Pacific regions.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.